WARRINGTON, Pa. , Oct. 03, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced that Craig Fraser , President and Chief Executive
Part 3 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…
Part 3 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…
HiRO and Differentia have signed a Memorandum of Understanding establishing a framework for joint development…
HiRO and Differentia have signed a Memorandum of Understanding establishing a framework for joint development…